Interaction between 3-Bromopyruvate and SC-514 in prostate cancer treatment

Prostate cancer (PCa) still remains a medical challenge to the world1 and it is becoming a common disease in the world.2 PCa account for 15% of all cancers in men worldwide.3 Prostate cancer is the most prevalent among the cancer related diseases and the second leading cause of cancer related death in USA.4 Prostate cancer poses a major economic limitation in humans. The economic limitation on patients makes prostate cancer one of the deadliest diseases. Patients with advanced stage of the disease have a low quality of life; they constantly visit the hospital for extremely expensive treatments. Regardless of the costly treatment of prostate cancer, there is life threatening transformations in the patient’s body system.5‒7